The extended interactions and Gla domain of blood coagulation factor Xa

Biochemistry

Volumn 42, Issue 26, 2003, Pages 7959-7966

  Wang, Stephanie X ^a   Hur, Eugene ^a   Sousa, Carolyn A ^b   Brinen, Linda ^b   Slivka, Eric J ^a   Fletterick, Robert J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; ENZYMES; HYDROGEN BONDS;

BLOOD COAGULATION FACTOR;

BIOCHEMISTRY;

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; CARBONYL DERIVATIVE; ECOTIN; GLUTAMINE; MAGNESIUM ION; PROTEINASE INHIBITOR; SERINE PROTEINASE; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; HUMAN; HYDROGEN BOND; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; STRUCTURE ANALYSIS;

1-CARBOXYGLUTAMIC ACID; BACTERIAL PROTEINS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FACTOR XA; HUMANS; MAGNESIUM; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PERIPLASMIC PROTEINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

EID: 0038723723     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi027320a     Document Type: Article

References (61)

1. Davie, E. W., Fujikawa, K., and Kisiel, W. (1991) The coagulation cascade: initiation, maintenance, and regulation, Biochemistry 30 (43), 10363-70.
2. Padmanabhan, K., et al. (1993) 232 (3), 947-66.
3. Kaiser, B. (2002) Factor Xa - a promising target for drug development, Cell Mol. Life Sci. 59 (2), 189-92.
4. Stubbs, M. T., and Bode, W. (1994) Coagulation factors and their inhibitors, Curr. Opin. Struct. Biol. 4 (6), 823-32.
5. Brandstetter, H., et al. (1996) X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition, J. Biol. Chem. 271 (47), 29988-92.
6. Wei, A., et al. (1998) Unexpected binding mode of tick anti-coagulant peptide complexed to bovine factor Xa, J. Mol. Biol. 283 (1), 147-54.
7. Kamata, K., et al. (1998) Structural basis for chemical inhibition of human blood coagulation factor Xa, Proc. Natl. Acad. Sci. U.S.A. 95 (12), 6630-5.
8. Adler, M., et al. (2000) Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa, Biochemistry 39 (41), 12534-42.
9. Maignan, S., et al. (2000) Crystal structures of human factor Xa complexed with potent inhibitors, J. Med. Chem. 43 (17), 3226-32.
10. Rezaie, A. R., and Yang, L. (2001) Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin, Biochim. Biophys. Acta 1528 (2-3), 167-76.
11. Chung, C. H., et al. (1983) Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases, J. Biol. Chem. 258 (18), 11032-8.
12. Seymour, J. L., et al. (1994) Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa, Biochemistry 33 (13), 3949-58.
13. Ulmer, J. S., et al. (1995) Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein, FEBS Lett. 365 (2-3), 159-63.
14. McGrath, M. E., et al. (1994) Macromolecular chelation as an improved mechanism of protease inhibition: structure of the ecotin-trypsin complex, EMBO J. 13 (7), 1502-7.
15. Perona, J. J., et al. (1997) Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix, Biochemistry 36 (18), 5381-92.
16. Waugh, S. M., et al. (2000) The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity, Nat. Struct. Biol. 7 (9), 762-5.
17. Wang, S. X., Esmon, C. T., and Fletterick, R. J. (2001) Crystal structure of thrombin-ecotin reveals conformational changes and extended interactions, Biochemistry 40 (34), 10038-46.
18. Furie, B., and Furie, B. C. (1988) The molecular basis of blood coagulation, Cell 53 (4), 505-18.
19. Nar, H., et al. (2001) Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors, Structure (Cambridge) 9 (1), 29-37.
20. Nelsestuen, G. L., Broderius, M., and Martin, G. (1976) Role of γ-carboxyglutamic acid. Cation specificity of prothrombin and factor X-phospholipid binding, J. Biol. Chem. 251 (22), 6886-93.
21. Prendergast, F. G., and Mann, K. G. (1977) Differentiation of metal ion-induced transitions of prothrombin fragment 1, J. Biol. Chem. 252 (3), 840-50.
22. Bloom, J. W., and Mann, K. G. (1978) Metal ion induced conformational transitions of prothrombin and prothrombin fragment 1, Biochemistry 17 (21), 4430-8.
23. Borowski, M., et al. (1986) Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin, J. Biol. Chem. 261 (32), 14969-75.
24. McGrath, M. E., et al. (1991) Expression of the protease inhibitor ecotin and its cocrystallization with trypsin, J. Mol. Biol. 222 (2), 139-42.
25. Yang, S. Q., et al. (1998) Ecotin: a serine protease inhibitor with two distinct and interacting binding sites, J. Mol. Biol. 279 (4), 945-57.
26. Otwinowski, Z., and Minor, W. (1997) Methods in Enzymology (Carter, C. W. and Sweet, R. M., Eds.) p 307-26, Academic Press, New York.
27. Brunger, A. T., et al. (1998) Crystallography and NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr. D4 (Pt 5), 905-21.
28. Hubbard, S. J., and Thornton, J. M. (1993) Naccess, computer program. Department of Biochemistry and Molecular Biology, University of College London.
29. Kleywegt, G. J. (1996) Use of noncrystallographic symmetry in protein structure refinement, Acta Crystallogr. D52, 842-57.
30. Browner, M. F., Fauman, E. B., and Fletterick, R. J. (1992) Tracking conformational states in allosteric transitions of phosphorylase, Biochemistry 31 (46), 11297-304.
31. Merritt, E. A., and Bacon, D. J. (1997) Raster3D: Photorealistic Molecular Graphics, Methods Enzymol. 277, 505-24.
32. Wallace, A. C., Laskowski, R. A., and Thornton, J. M. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions, Protein Eng. 8 (2), 127-34.
33. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA.
34. Schechter, I., and Berger, A. (1967) On the size of the active site in proteases. I. Papain, Biochem. Biophys. Res. Commun. 27 (2), 157-62.
35. Harris, J. L., et al. (2000) Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries, Proc. Natl. Acad. Sci. U.S.A. 97 (14), 7754-9.
36. Bianchini, E. P., et al. (2002) Mapping of the catalytic groove preferences of factor xa reveals an inadequate selectivity for its macromolecule substrates, J. Biol. Chem. 277 (23), 20527-34.
37. Le Bonniec, B. F., and Esmon, C. T. (1991) Glu-192-Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin, Proc. Natl. Acad. Sci. U.S.A. 88 (16), 7371-5.
38. Rezaie, A. R., and Esmon, C. T. (1993) Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors, J. Biol. Chem. 268 (27), 19943-8.
39. Rezaie, A. R., and Esmon, C. T. (1995) Contribution of residue 192 in factor Xa to enzyme specificity and function, J. Biol. Chem. 270 (27), 16176-81.
40. Krem, M. M., and Cera, E. D. (2002) Evolution of enzyme cascades from embryonic development to blood coagulation, Trends Biochem. Sci. 27 (2), 67-74.
41. Broze, G. J., Jr., Girard, T. J., and Novotny, W. F. (1990) Regulation of coagulation by a multivalent Kunitz-type inhibitor, Biochemistry 29 (33), 7539-46.
42. Kisiel, W. (1979) Molecular properties of the Factor V-activating enzyme from Russell's viper venom, J. Biol. Chem. 254 (23), 12230-4.
43. Guinto, E. R., et al. (1994) Glu192 → Gln substitution in thrombin yields an enzyme that is effectively inhibited by bovine pancreatic trypsin inhibitor and tissue factor pathway inhibitor, J. Biol. Chem. 269 (28), 18395-400.
44. van de Locht, A., et al. (1997) The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin, EMBO J. 16 (11), 2977-84.
45. Rezaie, A. R. (1996) Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificity, J. Biol. Chem. 271 (39), 23807-14.
46. Vijayalakshmi, J., et al. (1994) The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin, Protein Sci. 3 (12), 2254-71.
47. Rezaie, A. R. (2000) Heparin-binding exosite of factor Xa, Trends Cardiovasc. Med. 10 (8), 333-8.
48. Dennis, M. S., et al. (2000) Peptide exosite inhibitors of factor VIIa as anticoagulants, Nature 404 (6777), 465-70.
49. Fuentes-Prior, P., et al. (2000) Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex, Nature 404 (6777), 518-25.
50. Chuang, Y. J., et al. (2001) Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin, J. Biol. Chem. 276 (18), 14961-71.
51. 2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1, Biochemistry 31 (9), 2554-66.
52. Freedman, S. J., et al. (1995) Structure of the calcium ion-bound γ-carboxyglutamic acid-rich domain of factor IX, Biochemistry 34 (38), 12126-37.
53. Banner, D. W., et al. (1996) The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor, Nature 380 (6569), 41-6.
54. Freedman, S. J., et al. (1996) Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX, J. Biol. Chem. 271 (27), 16227-36.
55. Mizuno, H., et al. (2001) Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X, Proc. Natl. Acad. Sci. U.S.A. 98 (13), 7230-4.
56. Zhang, L., and Castellino, F. J. (1994) The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine 5 in the γ-carboxyglutamic acid domain, J. Biol. Chem. 269 (5), 3590-5.
57. Christiansen, W. T., et al. (1995) Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid Vesicles, Biochemistry 34 (33), 10376-82.
58. 2+-free Gla domain sheds light on membrane binding of blood coagulation proteins, Nat. Struct. Biol. 2 (6), 504-9.
59. Falls, L. A., et al. (2001) The ω-loop region of the human prothrombin γ-carboxyglutamic acid domain penetrates anionic phospholipid membranes, J. Biol. Chem. 276 (26), 23895-902.
60. Tulinsky, A., Park, C. H., and Skrzypczak-Jankun, E. (1988) Structure of prothrombin fragment 1 refined at 2.8 Å resolution, J. Mol. Biol. 202 (4), 885-901.
61. Kleywegt, G. J., and Brunger, A. T. (1996) Checking your imagination: applications of the free R value, Structure 4 (8), 897-904.